NASDAQ: PGEN
Precigen Inc Stock Ownership - Who owns Precigen?

Insider buying vs selling

Have Precigen Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harry Thomasian Jr.Chief Financial Officer2025-05-1651,441$1.45
$74.59kSell
Phil TennantChief Commercial Officer2025-05-1622,969$1.45
$33.31kSell
Donald P. LehrChief Legal Officer2025-05-1655,101$1.45
$79.90kSell
Rutul R. ShahChief Operating Officer2025-05-1658,096$1.45
$84.24kSell
Helen SabzevariPresident and CEO2025-05-16521,224$1.45
$755.77kSell
Fred HassanDirector2025-03-1336,206$1.74
$63.00kBuy
Jeffrey B. KindlerDirector2025-03-1339,655$1.74
$69.00kBuy
Randal J. KirkDirector2025-03-1357,471$1.74
$100.00kBuy
James S. TurleyDirector2025-03-1335,919$1.74
$62.50kBuy
Nancy H. AgeeDirector2025-03-1332,471$1.74
$56.50kBuy

1 of 2

PGEN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PGEN insiders and whales buy or sell their stock.

PGEN Shareholders

What type of owners hold Precigen Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Randal J. Kirk81.40%240,270,361$365.21MInsider
Trading Sa Ares6.99%20,647,152$31.38MInsider
Patient Capital Management LLC5.89%17,372,301$26.41MInstitution
Adage Capital Partners GP LLC3.82%11,276,000$17.14MInstitution
Blackrock Inc3.64%10,752,215$16.34MInstitution
Vanguard Group Inc2.98%8,795,959$13.37MInstitution
Iridian Asset Management LLC1.55%4,585,809$6.97MInstitution
Geode Capital Management LLC1.18%3,479,602$5.29MInstitution
Helen Sabzevari1.12%3,317,022$5.04MInsider
Parkman Healthcare Partners LLC1.08%3,191,343$4.85MInstitution

1 of 3

PGEN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PGEN22.68%77.32%Net BuyingNet Selling
SEPN66.63%33.37%Net BuyingNet Buying
ABVX50.08%0.00%
MREO13.97%4.19%Net Selling
CELC81.60%12.34%Net Selling

Precigen Stock Ownership FAQ

Who owns Precigen?

Precigen (NASDAQ: PGEN) is owned by 27.20% institutional shareholders, 92.74% Precigen insiders, and 0.00% retail investors. Randal J. Kirk is the largest individual Precigen shareholder, owning 240.27M shares representing 81.40% of the company. Randal J. Kirk's Precigen shares are currently valued at $365.21M.

If you're new to stock investing, here's how to buy Precigen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.